ArticleFrontiers in immunology2026

Biparatopic targeting of CD38 using CD38-specific trimeric antibody recruiters improves cytotoxicity against multiple myeloma.

Henry Risch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.